From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia - A Systematic Review

Ku Nurhasni Ku Abd Rahim, Hanin Farhana Kamaruzaman, Maznah Dahlui, Sharifa Ezat Wan Puteh

Research output: Contribution to journalArticle

Abstract

Objective: To identify and describe the various economic evaluation studies in Malaysia and to determine the range of incremental cost-effectiveness ratios (ICERs) as reported in these studies. Methods: A comprehensive search of the scientific electronic databases was conducted (Medline, EBM Reviews, Embase, and hand search) to identify all published economic evaluation studies related to Malaysian healthcare. Two researchers assessed the quality of selected studies using the Critical Appraisal Skills Programme (CASP) checklist and Quality of Health Economic Studies instrument. The assessment was also reviewed by expert members of the Technical Advisory Committee of Health Technology Economic Evaluations (TACHTEE). Results: A total of 64 full-text articles were assessed for eligibility and included in this systematic review. Thirty studies were partial economic evaluations; the full economic evaluations included 17 cost-effectiveness analyses and 17 cost-utility analyses. From all the reported ICERs, the majority (68%) were categorized as highly cost-effective (ICER of less than 1 gross domestic product (GDP) per capita per quality-adjusted life-years or disability-adjusted life-years gained). Conclusion: This review identifies information gaps and loopholes in health economics research in Malaysia. Additionally, this study provides the information that the majority of published interventions in Malaysia fell within the cost-effectiveness threshold of 1 GDP per capita per quality-adjusted life-years or disability-adjusted life-years gained.

Original languageEnglish
Pages (from-to)91-99
Number of pages9
JournalValue in Health Regional Issues
Volume21
DOIs
Publication statusPublished - May 2020

Fingerprint

Malaysia
Cost-Benefit Analysis
Delivery of Health Care
Quality-Adjusted Life Years
Gross Domestic Product
Economics
Health
Economic evaluation
Healthcare
Systematic review
Cost-effectiveness analysis
Biomedical Technology
Advisory Committees
Checklist
Incremental cost
Cost-effectiveness ratio
Health economics
Research Personnel
Outcome Assessment (Health Care)
Databases

Keywords

  • cost-effectiveness analysis
  • cost-effectiveness threshold
  • economic evaluations

ASJC Scopus subject areas

  • Economics, Econometrics and Finance (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy

Cite this

From Evidence to Policy : Economic Evaluations of Healthcare in Malaysia - A Systematic Review. / Ku Abd Rahim, Ku Nurhasni; Kamaruzaman, Hanin Farhana; Dahlui, Maznah; Wan Puteh, Sharifa Ezat.

In: Value in Health Regional Issues, Vol. 21, 05.2020, p. 91-99.

Research output: Contribution to journalArticle

Ku Abd Rahim, Ku Nurhasni ; Kamaruzaman, Hanin Farhana ; Dahlui, Maznah ; Wan Puteh, Sharifa Ezat. / From Evidence to Policy : Economic Evaluations of Healthcare in Malaysia - A Systematic Review. In: Value in Health Regional Issues. 2020 ; Vol. 21. pp. 91-99.
@article{8202c325f4524dee9e6f1b9c8f99e6a2,
title = "From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia - A Systematic Review",
abstract = "Objective: To identify and describe the various economic evaluation studies in Malaysia and to determine the range of incremental cost-effectiveness ratios (ICERs) as reported in these studies. Methods: A comprehensive search of the scientific electronic databases was conducted (Medline, EBM Reviews, Embase, and hand search) to identify all published economic evaluation studies related to Malaysian healthcare. Two researchers assessed the quality of selected studies using the Critical Appraisal Skills Programme (CASP) checklist and Quality of Health Economic Studies instrument. The assessment was also reviewed by expert members of the Technical Advisory Committee of Health Technology Economic Evaluations (TACHTEE). Results: A total of 64 full-text articles were assessed for eligibility and included in this systematic review. Thirty studies were partial economic evaluations; the full economic evaluations included 17 cost-effectiveness analyses and 17 cost-utility analyses. From all the reported ICERs, the majority (68{\%}) were categorized as highly cost-effective (ICER of less than 1 gross domestic product (GDP) per capita per quality-adjusted life-years or disability-adjusted life-years gained). Conclusion: This review identifies information gaps and loopholes in health economics research in Malaysia. Additionally, this study provides the information that the majority of published interventions in Malaysia fell within the cost-effectiveness threshold of 1 GDP per capita per quality-adjusted life-years or disability-adjusted life-years gained.",
keywords = "cost-effectiveness analysis, cost-effectiveness threshold, economic evaluations",
author = "{Ku Abd Rahim}, {Ku Nurhasni} and Kamaruzaman, {Hanin Farhana} and Maznah Dahlui and {Wan Puteh}, {Sharifa Ezat}",
year = "2020",
month = "5",
doi = "10.1016/j.vhri.2019.09.002",
language = "English",
volume = "21",
pages = "91--99",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - From Evidence to Policy

T2 - Economic Evaluations of Healthcare in Malaysia - A Systematic Review

AU - Ku Abd Rahim, Ku Nurhasni

AU - Kamaruzaman, Hanin Farhana

AU - Dahlui, Maznah

AU - Wan Puteh, Sharifa Ezat

PY - 2020/5

Y1 - 2020/5

N2 - Objective: To identify and describe the various economic evaluation studies in Malaysia and to determine the range of incremental cost-effectiveness ratios (ICERs) as reported in these studies. Methods: A comprehensive search of the scientific electronic databases was conducted (Medline, EBM Reviews, Embase, and hand search) to identify all published economic evaluation studies related to Malaysian healthcare. Two researchers assessed the quality of selected studies using the Critical Appraisal Skills Programme (CASP) checklist and Quality of Health Economic Studies instrument. The assessment was also reviewed by expert members of the Technical Advisory Committee of Health Technology Economic Evaluations (TACHTEE). Results: A total of 64 full-text articles were assessed for eligibility and included in this systematic review. Thirty studies were partial economic evaluations; the full economic evaluations included 17 cost-effectiveness analyses and 17 cost-utility analyses. From all the reported ICERs, the majority (68%) were categorized as highly cost-effective (ICER of less than 1 gross domestic product (GDP) per capita per quality-adjusted life-years or disability-adjusted life-years gained). Conclusion: This review identifies information gaps and loopholes in health economics research in Malaysia. Additionally, this study provides the information that the majority of published interventions in Malaysia fell within the cost-effectiveness threshold of 1 GDP per capita per quality-adjusted life-years or disability-adjusted life-years gained.

AB - Objective: To identify and describe the various economic evaluation studies in Malaysia and to determine the range of incremental cost-effectiveness ratios (ICERs) as reported in these studies. Methods: A comprehensive search of the scientific electronic databases was conducted (Medline, EBM Reviews, Embase, and hand search) to identify all published economic evaluation studies related to Malaysian healthcare. Two researchers assessed the quality of selected studies using the Critical Appraisal Skills Programme (CASP) checklist and Quality of Health Economic Studies instrument. The assessment was also reviewed by expert members of the Technical Advisory Committee of Health Technology Economic Evaluations (TACHTEE). Results: A total of 64 full-text articles were assessed for eligibility and included in this systematic review. Thirty studies were partial economic evaluations; the full economic evaluations included 17 cost-effectiveness analyses and 17 cost-utility analyses. From all the reported ICERs, the majority (68%) were categorized as highly cost-effective (ICER of less than 1 gross domestic product (GDP) per capita per quality-adjusted life-years or disability-adjusted life-years gained). Conclusion: This review identifies information gaps and loopholes in health economics research in Malaysia. Additionally, this study provides the information that the majority of published interventions in Malaysia fell within the cost-effectiveness threshold of 1 GDP per capita per quality-adjusted life-years or disability-adjusted life-years gained.

KW - cost-effectiveness analysis

KW - cost-effectiveness threshold

KW - economic evaluations

UR - http://www.scopus.com/inward/record.url?scp=85074369745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074369745&partnerID=8YFLogxK

U2 - 10.1016/j.vhri.2019.09.002

DO - 10.1016/j.vhri.2019.09.002

M3 - Article

C2 - 31698173

AN - SCOPUS:85074369745

VL - 21

SP - 91

EP - 99

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

ER -